Iowa Governor Bans AI in Prior Authorization Decisions

Context Governor Kim Reynolds signed House File 2635 into law after unanimous legislative approval. The measure targets a long‑standing grievance among physicians: the opaque use of algorithms to reject treatment requests before patients receive care. By removing AI from the decision chain, the state aims to restore clinical judgment and reduce administrative delays.

Key Facts - Health insurers may no longer employ artificial‑intelligence systems to deny prior‑authorization requests. The ban applies to any algorithm that influences the final denial decision. - Recommended cancer screenings, such as mammograms and colonoscopies, are exempt from prior‑authorization requirements, ensuring timely preventive care. - Insurers cannot impose financial penalties on physicians who refer patients to out‑of‑network providers, preserving doctors’ referral autonomy.

What It Means For patients, the law eliminates a layer of automated denial that could delay essential services. A 2022 cohort study of 12,000 Medicare beneficiaries found that AI‑driven prior‑auth denials increased wait times by an average of 14 days, though the study could not prove causation. By removing AI from the process, Iowa expects to shorten approval cycles, especially for time‑sensitive cancer screenings. For providers, the exemption for cancer screenings removes a common bottleneck, allowing doctors to schedule preventive procedures without insurer clearance. The protection against out‑of‑network penalties also means physicians can refer patients to specialists outside the insurer’s network without risking reduced reimbursement rates. For insurers, the legislation eliminates a cost‑saving tool. Companies will need to rely on human reviewers, which may increase administrative overhead. However, the law does not prohibit insurers from using AI for other functions, such as fraud detection, where a 2021 randomized controlled trial of 8,000 claims showed a 22% reduction in false‑positive fraud alerts. Overall, the bill reflects a shift toward clinician‑led decision making in Iowa’s health‑care system. Stakeholders will monitor whether the removal of AI from prior‑auth decisions improves access without inflating costs.

Looking ahead, watch for early data on approval timelines and claim processing costs as insurers adapt to the new requirements.